Immune Cells in Blood Drive Cognitive Aging; Blocking Them Improves Memory

A groundbreaking study published in *Immunity* suggests that a specific type of immune cell circulating in the bloodstream plays a crucial role in age-related cognitive decline. This research, primarily conducted on mice, indicates that blocking the effects of these cells could potentially reverse memory impairments. This opens new avenues for understanding and treating cognitive aging, offering a fresh perspective on how the body's immune system influences brain health over time. The cells in question are a group of T cells known as CD8+ cells. While their primary function is to combat pathogens, previous research showed that as organisms age, some CD8+ cells infiltrate brain tissue, where they release an enzyme that causes inflammation and hinders brain cell regeneration. However, the role of the larger population of CD8+ cells that remain in the bloodstream, not infiltrating the brain, was previously unclear, leaving a significant gap in our understanding of their broader impact on aging. The latest study sheds light on these "non-infiltrating" CD8+ T cells, demonstrating that they actively contribute to cognitive decline from outside the brain. Researchers found that these cells influence brain function by secreting inflammatory factors into the blood, which then impact the brain. This external influence is a significant revelation, as noted by neuroimmunologist Paloma Navarro Negredo, who called it "entirely new" and highlighted its importance in redefining our understanding of neuroimmunological interactions. To uncover these mechanisms, Saul Villeda's team at the University of California, San Francisco, employed a technique called parabiosis, linking the circulatory systems of young and old mice. This allowed them to observe that the older non-infiltrating CD8+ cells were driving the aging process. Further experiments involved injecting young mice with either old or young CD8+ cells. Mice receiving aged cells showed lower expression of genes linked to mental sharpness in the hippocampus, a brain region vital for memory and learning, providing molecular evidence for their detrimental effects. Functionally, mice injected with old cells performed worse in object-recognition tasks and maze challenges compared to those with young cells, demonstrating clear cognitive impairments. Crucially, the researchers propose that blocking the effects of these immune cells in the blood could be a more practical and accessible treatment strategy than attempting to target cells directly within the brain. As co-author Saul Villeda emphasizes, "We don’t even have to get into the brain to start treating cognitive decline. We can actually block things in blood to have an impact on memory." This discovery offers a promising, less invasive approach to combating age-related memory loss, potentially paving the way for novel therapeutic interventions.